CD4 and COVID-19: Over time, contradictory results on the clinical outcomes of COVID-19 have emerged [1,2], but collectively, the scientific literature agrees that a lack of viro-immunological control (low CD4+T lymphocyte cell counts and unsuppressed viral load) should be considered as a risk factor for the clinical progression of COVID-19 in PLWH [3].